Fundraising FoxOrganovo, Inc.
2 known investors
Find your way into Organovo, Inc.
Sign up to find every way you can get introduced to Organovo, Inc.
- Your email: who you already know at Organovo, Inc., and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Organovo, Inc. team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Organovo develops regenerative medicine therapies using bioprinting technology to treat serious liver diseases. The company serves the pharmaceutical and biotech sectors with innovative therapeutic approaches based on decades of leadership expertise in life sciences.
Founders & leadership
KM
Keith MurphyExecutive Chairman
Investors · 2
Founder mafia
2 people who came through Organovo, Inc. went on to found or lead other companies.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $221.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $221.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $290.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2010 | $125.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $142.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Organovo, Inc. do?
- Organovo develops regenerative medicine therapies using bioprinting technology to treat serious liver diseases. The company serves the pharmaceutical and biotech sectors with innovative therapeutic approaches based on decades of leadership expertise in life sciences.
- Who are Organovo, Inc.'s investors?
- Organovo, Inc.'s investors include Aurum Venture Partners, Khosla Ventures.